Santen Pharmaceutical Co., Ltd. (SNPHY)
11.78
-0.07
(-0.59%)
USD |
OTCM |
Aug 24, 16:00
Santen Pharmaceutical Debt to Equity Ratio : 0.1033 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1033 |
| March 31, 2026 | 0.117 |
| December 31, 2025 | 0.1276 |
| September 30, 2025 | 0.1297 |
| June 30, 2025 | 0.1251 |
| March 31, 2025 | 0.1196 |
| December 31, 2024 | 0.1112 |
| September 30, 2024 | 0.1095 |
| June 30, 2024 | 0.1064 |
| March 31, 2024 | 0.1149 |
| December 31, 2023 | 0.1126 |
| September 30, 2023 | 0.1104 |
| June 30, 2023 | 0.1153 |
| March 31, 2023 | 0.1232 |
| December 31, 2022 | 0.1233 |
| September 30, 2022 | 0.123 |
| June 30, 2022 | 0.0649 |
| March 31, 2022 | 0.0976 |
| December 31, 2021 | 0.066 |
| September 30, 2021 | 0.0623 |
| June 30, 2021 | 0.0322 |
| March 31, 2021 | 0.0327 |
| December 31, 2020 | 0.0802 |
| September 30, 2020 | 0.0837 |
| June 30, 2020 | 0.0933 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0407 |
| December 31, 2019 | 0.1024 |
| September 30, 2019 | 0.1032 |
| June 30, 2019 | 0.1047 |
| March 31, 2019 | 0.014 |
| December 31, 2018 | 0.0782 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.0266 |
| December 31, 2017 | 0.0816 |
| September 30, 2017 | 0.0881 |
| June 30, 2017 | 0.0237 |
| March 31, 2017 | 0.0664 |
| December 31, 2016 | 0.0358 |
| September 30, 2016 | 0.0445 |
| June 30, 2016 | 0.0533 |
| March 31, 2016 | 0.0865 |
| December 31, 2015 | 0.1091 |
| September 30, 2015 | 0.1243 |
| June 30, 2015 | 0.1581 |
| March 31, 2015 | 0.0577 |
| December 31, 2014 | 0.205 |
| September 30, 2014 | 0.186 |
| June 30, 2014 | 0.1936 |
| March 31, 2014 | 0.0008 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 0.6536 |
| Daiichi Sankyo Co., Ltd. | 0.2939 |
| Eisai Co., Ltd. | 0.2993 |
| Chugai Pharmaceutical Co., Ltd. | 0.0087 |
| Ono Pharmaceutical Co., Ltd. | 0.1351 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.559B |
| Total Liabilities (Quarterly) | 717.30M |
| Shareholders Equity (Quarterly) | 1.847B |
| Current Ratio | 2.816 |
| Net Debt Paydown Yield | 0.18% |